SCHEMBL30064094

SCHEMBL30064094

O=c1cc(O)c2ccncc2[nH]1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 6/20 1.00
KDM4E B2RXH2 2/20 0.58
ALDH1A1 P00352 2/20 0.58
DAO P14920 2/20 0.51
KDM5C P41229 1/20 0.49
KDM5B Q9UGL1 1/20 0.49
PARP1 P09874 1/20 0.49
CHUK O15111 5/20 0.46
GABRP O00591 1/20 0.46
GABRD O14764 1/20 0.46
IKBKB O14920 1/20 0.46
AURKA O14965 1/20 0.46
PIM1 P11309 1/20 0.46
TOP1 P11387 1/20 0.46
GABRA1 P14867 1/20 0.46
IDO1 P14902 1/20 0.46
HPGD P15428 1/20 0.46
GABRB1 P18505 1/20 0.46
GABRG2 P18507 1/20 0.46
MAOA P21397 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3242090 1.00 KDM5A (1.00) KDM5AKDM4EALDH1A1DAOKDM5C
SCHEMBL29390241 0.86 KDM5A (0.75) KDM5AKDM4EALDH1A1DAOPARP1
SCHEMBL4754006 0.86 KDM5A (0.75) KDM5AKDM4EALDH1A1DAOPARP1
SCHEMBL30474111 0.80 KDM5A (0.67) KDM5AKDM4EALDH1A1KDM5BPARP1
SCHEMBL19984551 0.80 KDM5A (0.67) KDM5AKDM4EALDH1A1KDM5BPARP1
SCHEMBL4756721 0.79 KDM5A (0.65) KDM5AKDM4EALDH1A1PARP1CHUK
SCHEMBL246359 0.79 KDM5A (0.65) KDM5AKDM4EALDH1A1KDM5CKDM5B
SCHEMBL26347775 0.77 KDM5A (0.62) KDM5AKDM4EALDH1A1KDM5CKDM5B
Trifluoroacetic Acid SCHEMBL31704032 0.76 KDM5A (0.60) KDM5AKDM4EALDH1A1DAOPARP1
SCHEMBL1193735 0.73 KDM4E (1.00) KDM5AKDM4EALDH1A1DAOHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174696-A1 2,8-DIAZASPIRO[4.5]DECANE COMPOUNDS GENENTECH, INC. (US) 2024-05-30 US disclosed
EP-4347594-A1 2, 8-DIAZASPIRO [4.5] DECANE COMPOUNDS Genentech, Inc. (US) 2024-04-10 EP disclosed
CN-117425654-A 2, 8-diazaspiro [4.5] decane compounds 基因泰克公司 2024-01-19 CN disclosed
WO-2022253341-A1 2, 8-DIAZASPIRO [4.5] DECANE COMPOUNDS GENENTECH, INC. (US) 2022-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174696-A1 2,8-DIAZASPIRO[4.5]DECANE COMPOUNDS LATS1, LATS2, GLS2 KDM5A 1763/4885KDM4E 1411/4885ALDH1A1 2460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.